For decades, Mary Kay has committed to developing irresistible products that help fight signs of aging in women and men. Cutting-edge skin care research is a primary focus of the Mary Kay Research and Development team. Products are clinically tested to be effective on a variety of skin tones and all skin types to ensure Mary Kay is delivering meaningful benefits to its customers.

Inspiration can come from anywhere. We have scientists in our lab who have identified innovative technologies by going to a juice bar discovering a new botanical extract for use in skin care! Our scientists conduct research on thousands of ingredients and how they benefit every skin type, resulting in fantastic patented materials that consumers love.

So, what are our scientists up to lately? Mary Kay will reveal new research at two exciting skin care science events over the next several weeks: the Skin of Color Society Symposium on February 28 and the American Academy of Dermatology Annual Meeting from March 1 to March 5.

Dr. Shoná Burkes-Henderson, Associate Principal Scientist, Clinical Research, is scheduled to reveal research on the effect of navy bean extract and its capability to regulate pigmentation at the Skin of Color Society Symposium, and a new approach to possibly help facial erythema at the American Academy of Dermatology Annual Meeting.

If you’ve used our popular Time Wise® Tone-Correcting Serum, then you’re already familiar with some of the benefits of the navy bean. Its effect on improving the brightness of skin and the appearance of overall evenness of skin tone was an amazing discovery.

The upcoming skin-care events are the latest in a series of Mary Kay partnerships with the scientific and academic communities committed to funding skin health research and development. Every year, Mary Kay conducts hundreds of thousands of scientific tests on products and ingredients to ensure the highest standards of safety, quality and performance. Mary Kay holds more than 1,500 patents for products, technologies and packaging designs in its global portfolio. Recently, the company announced the opening of a more than $100 million state-of-the-art manufacturing and R&D facility in Lewisville, Texas.